Search
Menu
Excelitas Technologies Corp. - X-Cite Vitae LB 11/24

Biolase Receives Eye Treatment Patent

Facebook X LinkedIn Email
IRVINE, Calif., Sept. 12, 2011 — Dental laser manufacturer Biolase Technology Inc. has received US Patent No. 7,997,279, titled “Methods for Treating Eye Conditions,” from the US Patent and Trademark Office, the company announced recently. The new patent is the 13th issued in the ophthalmic family, with 20 others pending. It continues and expands US Patent No. 7,665,467, with broad claims covering the use of laser technology for treating various conditions of the eye, including presbyopia — the inability to focus sharply for near vision — and it opens up opportunities in oculoplastics as well as...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: September 2011
    Glossary
    ophthalmology
    Ophthalmology is a branch of medicine that focuses on the anatomy, physiology, and diseases of the eyes and visual system. Ophthalmologists are medical doctors who specialize in the diagnosis, treatment, and prevention of eye disorders and diseases. They are trained to provide comprehensive eye care, including medical, surgical, and optical interventions. Key areas within ophthalmology include: General eye care: Ophthalmologists perform routine eye examinations to assess visual acuity,...
    presbyopia
    A state in which the human eye has very little or no power of accommodation. A common and normal condition in the eyes of those age 50 and older.
    Americasbiolase technologyBiophotonicsBusinessCaliforniacataractsDelawaredental laserseye diseaseglaucomaOculaseoculoplasticsophthalmic stentsophthalmologypresbyopiaUS Patent No. 7665467US Patent No. 7997279Lasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.